INGLEWOOD

V  E  N  T  U  R  E  S

Helping Healthcare Entrepreneurs Succeed

12526 High Bluff Drive Suite  300                             San Diego, CA  92130
(858)792-3579
(858)792-3417 - fax info@inglewoodventures.com

Below are recent articles/press releases about IngleWood Ventures and some of its Portfolio Companies (chronologically by release  date):

May, 2006 - Conforma $250 million Buy-out

June 2005 - Conforma Therapeutics Corporation Acquires Late Stage Anti-Cancer Compound from Sumitomo Pharmaceuticals Co., Ltd.

May 2005 - Conforma Therapeutics Completes Round of Private Financing to Support Clinical Development

May 2005 Cylene Pharmaceuticals Raises $26.3 Million in Series B. Financing

November 2004 - Scimagix announces merge with BioImagene

November 2004 - Digirad Corp announces 23% rise in 3rd Quarter revenue

October 2004 - Conforma Therapeutics appoints Dr. Jager as VP

October 2004 - Digirad Corp Wins First Place High Tech Award

September 2004 - Quorex Pharmaceuticals Names new CEO

August 2004 - Conforma Therapeutics enters clinical trials

July 2004 - CardioNet Nominated for World Technology Award

June 2004 - CardioNet's CEO, Jim Sweeney, Named Entrepreneur of the Year

June 2004 -  NewBiotics Acquired by Celmed

June 2004 Digirad IPO

June 2004 - San Diego Best in Biotech

May 2004 - CardioNet Named to Red Herring's Top 100 Private Companies

October 2, 2003 - CardioNet Wins National Award for Technology Innovation in Healthcare

September 18, 2003 - Conforma Therapeutics Closes $30 Million Financing

September 11, 2003 - Targeted Molecules Corporation completes $4 Million Financing to Advance First Product to Clinical Testing

October 15, 2003 - Cylene Name Change & Bill Rice Named New CEO

August 20, 2003 - Digirad Reports Record Revenue for the Sixth Consecutive Quarter

August 5, 2003 - Digirad Named One of Top 50 Fastest Growing Technology Companies in San Diego

May 19, 2003 - Cengent Therapeutics Is Formed By the Merger of Structural Bioinformatics and GeneFormatics

January 9, 2003 - CardioNet Raises an Additional $13 Million of Venture Capital

November 2002 - Venture Reporter - The Top 25 Biotechnology Venture Capitalists

August 6, 2002 - Quorex Pharmaceuticals Closes $10.6 Million Extension to Series B Round

April 24, 2002 - Digirad Secures First Closing of Additional Equity Funding Commitments Totaling $16.0 Million.

March 11, 2002 - CardioNet Closes $18.5 Million Financing Round

January 7, 2002 - NewBiotics begins NB1011 Phase I/II Clinical Trial for Colon Cancer

October 17, 2001 - Cyternex (Cylene) Raises $3.5 Million Series A Financing

July 18, 2001 - Scimagix Secures $25 Million Funding

October 31, 2000 - Targeted Molecules Corporation Founded by a Leading Scientist from the Burnham Institute

May 2000 - IngleWood Leads First Round for CardioNet

October 13, 1999 - "New Venture Cap Firm Walks Where Others Fear to Tread", San Diego Daily Transcript - front page